Data / Form D filings / UNIGENE LABORATORIES INC
UNIGENE LABORATORIES INC: Form D filings
UNIGENE LABORATORIES INC, a biotechnology company in Boonton, NJ, filed 3 Form D notices with the SEC between 2010 and 2013. The latest, on April 22, 2013, reports $750,000 sold of a $750,000 offering to 1 investor.
Find out what UNIGENE LABORATORIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 81 FULTON STREET, Boonton, NJ, 07005
- Phone
- (973) 265-1100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 352747
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2013 | New notice | $750,000 | $750,000 | $0 | 1 | Apr 8, 2013 | sec.gov |
| Oct 9, 2012 | New notice | $7,500,000 | $4,000,000 | $3,500,000 | 4 | Sep 21, 2012 | sec.gov |
| Mar 29, 2010 | New notice | $36,000,000 | $33,000,000 | $3,000,000 | 1 | Mar 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nozer M. Mehta | Executive Officer | |
| Brian M. Zietsman | Executive Officer | |
| Roxanne P. Tavakkol | Executive Officer | |
| Richard Levy | Director | |
| Paul P. Shields | Executive Officer | |
| Jack M. Wyszomierski | Director | |
| Theron M. Odlaug | Director | |
| Thomas M. Sabatino, Jr. | Director | |
| Joel M. Tune | Director | |
| Ashleigh M. Palmer | Executive Officer, Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Apr 22, 2013 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what UNIGENE LABORATORIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.